论文部分内容阅读
发表在《Diabetes Care》上的欧洲大规模横断面研究发现,接近10%的成人新发糖尿病患者存在糖尿病相关的自身免疫抗体。自身免疫糖尿病的部分病人在诊断时不需要胰岛素治疗,尽管他们倾向于更年轻,更瘦,但不是所有的患者都展现出与自身免疫抗体阴性的2型糖尿病患者有绝对的临床特征方面的差异。仅仅用筛选抗体,尤其是GADA,就能够明确的做出分辨。6,156位入组的病人年龄在30～70岁(平均54.4岁)且不会超过糖尿病诊断后5年(平均2.2年)。大部分(84.6%)是白人,58.5%为男性,这些病人来自于2004～2007年间9个欧洲国家
A European large-scale cross-sectional study published in “Diabetes Care” found that diabetes-related autoimmune antibodies were present in nearly 10% of adults with new-onset diabetes. Some patients with autoimmune diabetes do not require insulin therapy at the time of diagnosis and although they tend to be younger and thinner, not all patients show absolute clinical characteristics in patients with autoimmune-negative type 2 diabetes . Only by screening antibodies, especially GADA, can be clearly resolved. Of the 6,156 enrolled patients, those aged 30-70 years (mean 54.4 years) did not surpass 5 years after diag- nosis (mean 2.2 years). The majority (84.6%) were white and 58.5% were men. These patients came from 9 European countries from 2004 to 2007